APA (7th ed.) Citation

Kenealy, M., Giri, P., Filshie, R., Ho, S., Nicol, A., Cowan, L., . . . Seymour, J. (2011). 60 Results of a phase II study of thalidomide (Thai) and azacitidine (Aza) in patients with clinically advanced myelodysplastic syndromes (MDS). Leukemia Research, 35, S22. https://doi.org/10.1016/S0145-2126(11)70062-5

Chicago Style (17th ed.) Citation

Kenealy, M., P. Giri, R. Filshie, S.-J Ho, A. Nicol, L. Cowan, E. Link, and J.F Seymour. "60 Results of a Phase II Study of Thalidomide (Thai) and Azacitidine (Aza) in Patients with Clinically Advanced Myelodysplastic Syndromes (MDS)." Leukemia Research 35 (2011): S22. https://doi.org/10.1016/S0145-2126(11)70062-5.

MLA (9th ed.) Citation

Kenealy, M., et al. "60 Results of a Phase II Study of Thalidomide (Thai) and Azacitidine (Aza) in Patients with Clinically Advanced Myelodysplastic Syndromes (MDS)." Leukemia Research, vol. 35, 2011, p. S22, https://doi.org/10.1016/S0145-2126(11)70062-5.